SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 19 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,136 | -28.2% | 108,485 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $11,326 | +84.9% | 108,485 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $6,124 | +20.1% | 108,485 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $5,099 | -27.2% | 108,485 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -58.8% | 108,485 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $17,000 | -67.3% | 108,485 | 0.0% | 0.00% | -57.1% |
| Q1 2022 | $52,000 | -74.9% | 108,485 | -6.3% | 0.01% | -73.1% |
| Q4 2021 | $207,000 | – | 115,785 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 358,349 | $520,000 | 0.01% |
| Shaolin Capital Management LLC | 823,999 | $156,000 | 0.00% |
| Yakira Capital Management, Inc. | 108,485 | $17,000 | 0.00% |
| Radcliffe Capital Management, L.P. | 55,692 | $81,000 | 0.00% |
| EQUITEC PROPRIETARY MARKETS, LLC | 45,000 | $7,000 | 0.00% |
| MARSHALL WACE, LLP | 285,000 | $413,000 | 0.00% |
| MORGAN STANLEY | 148,939 | $22,000 | 0.00% |
| Walleye Trading LLC | 15,505 | $2,000 | 0.00% |
| Citadel Advisors | 18,711 | $3,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,944 | $2,000 | 0.00% |